This brand name is authorized in Brazil, Cyprus, Germany, Ecuador, Estonia, Spain, France, Hong Kong, Lithuania, Mexico, Poland, Romania, Singapore, Tunisia, Turkey
The drug DUSPATALIN contains one active pharmaceutical ingredient (API):
1
Mebeverine
UNII 15VZ5AL4JN - MEBEVERINE HYDROCHLORIDE
|
Mebeverine is a musculotropic antispasmodic with a direct action on the smooth muscle of the gastrointestinal tract, relieving spasm without affecting normal gut motility. |
Below package inserts are available for further reading:
Title | Information Source | Document Type | |
---|---|---|---|
DUSPATALIN Modified release capsule, hard | Υπουργείο Υγείας (CY) | MPI, EU: SmPC |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
ATC code | Group title | Classification |
---|---|---|
A03AA04 | Mebeverine | A Alimentary tract and metabolism → A03 Drugs for functional gastrointestinal disorders → A03A DRUGS FOR FUNCTIONAL BOWEL DISORDERS → A03AA Synthetic anticholinergics, esters with tertiary amino group |
This drug has been assigned below unique identifiers within the countries it is being marketed:
Country | Identification scheme | Identifier(s) |
---|---|---|
Country: BR | Câmara de Regulação do Mercado de Medicamentos | Identifier(s): 500214050031608, 500216020034303 |
Country: DE | Bundesinstitut für Arzneimittel und Medizinprodukte | Identifier(s): 00009923, 00009946, 00055248, 00111573, 01184700, 01184717, 02742349, 02742355, 06467124, 06467130, 12490966, 16352899 |
Country: EC | Agencia Nacional de Regulación, Control y Vigilancia Sanitaria | Identifier(s): 29.200-03-10, 5860-MEE-0121 |
Country: EE | Ravimiamet | Identifier(s): 1136696, 1885181 |
Country: ES | Centro de información online de medicamentos de la AEMPS | Identifier(s): 53900 |
Country: FR | Base de données publique des médicaments | Identifier(s): 61703401 |
Country: HK | Department of Health Drug Office | Identifier(s): 32074, 38954 |
Country: LT | Valstybinė vaistų kontrolės tarnyba | Identifier(s): 1015607, 1070284, 1079069, 1081606 |
Country: MX | Comisión Federal para la Protección contra Riesgos Sanitarios | Identifier(s): 259M2009, 314M2002 |
Country: PL | Rejestru Produktów Leczniczych | Identifier(s): 100020985, 100078507, 100261074, 100266746, 100274036, 100292241, 100300294, 100301365, 100303619, 100306428, 100312156, 100325064, 100332710, 100343375, 100348616, 100350079, 100369512, 100385400, 100390104, 100392379, 100407661, 100421098, 100421721, 100424702, 100426322, 100429504, 100433658, 100457086, 100464331 |
Country: RO | Agenția Națională a Medicamentului și a Dispozitivelor Medicale | Identifier(s): W69081001, W69081002 |
Country: SG | Health Sciences Authority | Identifier(s): 07666P |
Country: TN | Direction de la Pharmacie et du Médicament | Identifier(s): 9003741 |
Country: TR | İlaç ve Tıbbi Cihaz Kurumu | Identifier(s): 8699820030360, 8699820120030, 8699820700041 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.